Archive - March 2018
Azar hints ACA health plans could see laxer regulation
UCB’s Vimpat gets NHS green light in Wales
NICE u-turn on treatment for giant cell arteritis
Surprise finding could lead to new MS treatments
UK launch for Europe’s first Herceptin biosimilar
US green lights novel HIV treatment
EMA recommends suspension, recall of Zinbryta
Cigna to buy Express Scripts in $67 billion deal